• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumour microenvironment: Modulating effects, challenges, and future perspectives of oncolytic virotherapy in Astrocytoma treatment.

作者信息

Awuah Wireko Andrew, Huang Helen, Kalmanovich Jacob, Mehta Aashna, Kundu Mrinmoy, Toufik Abdul Rahman, Tanna Resham, Hasan Mohammad Mehedi, Alexiou Athanasios, Sikora Vladyslav

机构信息

Sumy State University, Sumy, Ukraine.

Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.

出版信息

Ann Med Surg (Lond). 2022 Aug 28;82:104508. doi: 10.1016/j.amsu.2022.104508. eCollection 2022 Oct.

DOI:10.1016/j.amsu.2022.104508
PMID:36186495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9519464/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a41b/9519464/0a2e36b27faf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a41b/9519464/0a2e36b27faf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a41b/9519464/0a2e36b27faf/gr1.jpg

相似文献

1
Tumour microenvironment: Modulating effects, challenges, and future perspectives of oncolytic virotherapy in Astrocytoma treatment.肿瘤微环境：溶瘤病毒疗法在星形细胞瘤治疗中的调节作用、挑战及未来展望
Ann Med Surg (Lond). 2022 Aug 28;82:104508. doi: 10.1016/j.amsu.2022.104508. eCollection 2022 Oct.
2
The Multifaceted Role of Macrophages in Oncolytic Virotherapy.巨噬细胞在溶瘤病毒治疗中的多方面作用。
Viruses. 2021 Aug 9;13(8):1570. doi: 10.3390/v13081570.
3
Oncolytic virotherapy: Challenges and solutions.溶瘤病毒治疗学：挑战与对策。
Curr Probl Cancer. 2021 Feb;45(1):100639. doi: 10.1016/j.currproblcancer.2020.100639. Epub 2020 Aug 15.
4
Oncolytic Viruses: The Best is Yet to Come.溶瘤病毒：好戏还在后头。
Curr Cancer Drug Targets. 2018;18(2):109-123. doi: 10.2174/1568009617666170206111609.
5
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.溶瘤病毒治疗与多发性骨髓瘤的微环境。
Int J Mol Sci. 2021 Feb 24;22(5):2259. doi: 10.3390/ijms22052259.
6
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?溶瘤病毒治疗胰腺导管腺癌：失望多年后的一线希望？
Cytokine Growth Factor Rev. 2020 Dec;56:141-148. doi: 10.1016/j.cytogfr.2020.07.015. Epub 2020 Aug 8.
7
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma.免疫细胞在单纯疱疹病毒溶瘤疗法治疗脑胶质瘤中的意义。
Brain Tumor Pathol. 2022 Apr;39(2):57-64. doi: 10.1007/s10014-022-00431-8. Epub 2022 Apr 6.
8
Oncolytic virotherapy - Forging its place in the immunomodulatory paradigm for Multiple Myeloma.溶瘤病毒治疗 - 在多发性骨髓瘤的免疫调节范式中占据一席之地。
Cancer Treat Res Commun. 2021;29:100473. doi: 10.1016/j.ctarc.2021.100473. Epub 2021 Oct 9.
9
Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model.增强溶瘤病毒治疗：基于 Voronoi 细胞模型的观察。
J Theor Biol. 2020 Jan 21;485:110052. doi: 10.1016/j.jtbi.2019.110052. Epub 2019 Oct 15.
10
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis.溶瘤病毒疗法增强化疗效果：数学与最优控制分析
Math Biosci Eng. 2018 Dec 1;15(6):1435-1463. doi: 10.3934/mbe.2018066.

引用本文的文献

1
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review.细胞因子和趋化因子在肿瘤微环境中的矛盾作用：全面综述。
Eur J Med Res. 2024 Feb 15;29(1):124. doi: 10.1186/s40001-024-01711-z.

本文引用的文献

1
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.工程策略增强溶瘤病毒在癌症免疫治疗中的作用。
Signal Transduct Target Ther. 2022 Apr 6;7(1):117. doi: 10.1038/s41392-022-00951-x.
2
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?非癌细胞的感染：溶瘤病毒疗法的障碍还是支持？
Mol Ther Oncolytics. 2022 Feb 12;24:663-682. doi: 10.1016/j.omto.2022.02.004. eCollection 2022 Mar 17.
3
Genetic Modifications That Expand Oncolytic Virus Potency.增强溶瘤病毒效力的基因改造。
Front Mol Biosci. 2022 Jan 26;9:831091. doi: 10.3389/fmolb.2022.831091. eCollection 2022.
4
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.溶瘤病毒免疫治疗：脑胶质瘤治疗的新选择
Front Immunol. 2021 Oct 5;12:721830. doi: 10.3389/fimmu.2021.721830. eCollection 2021.
5
Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.免疫病毒疗法治疗脑胶质瘤和其他恶性脑肿瘤。
Neurosurg Clin N Am. 2021 Apr;32(2):265-281. doi: 10.1016/j.nec.2020.12.008. Epub 2021 Feb 18.
6
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response.胶质母细胞瘤溶瘤病毒疗法的个性化：寻找反应生物标志物
Cancers (Basel). 2021 Feb 4;13(4):614. doi: 10.3390/cancers13040614.
7
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.溶瘤病毒联合癌症免疫治疗：开创新一代癌症治疗。
Front Immunol. 2020 Apr 28;11:683. doi: 10.3389/fimmu.2020.00683. eCollection 2020.
8
Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.更正：用抗程序性死亡蛋白1单链可变片段武装1型溶瘤单纯疱疹病毒用于实验性胶质母细胞瘤治疗。
Clin Cancer Res. 2020 Feb 1;26(3):758. doi: 10.1158/1078-0432.CCR-19-4091.
9
Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies.加热升温：溶瘤病毒使肿瘤“升温”并适合检查点阻断免疫疗法。
Oncoimmunology. 2018 Mar 13;7(8):e1442169. doi: 10.1080/2162402X.2018.1442169. eCollection 2018.
10
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.一项评估M032（一种表达IL-12的基因工程单纯疱疹病毒1型）用于复发性/进展性多形性胶质母细胞瘤、间变性星形细胞瘤或胶质肉瘤患者的I期临床试验设计。
Hum Gene Ther Clin Dev. 2016 Jun;27(2):69-78. doi: 10.1089/humc.2016.031.